Director of Research
In the Ley Group, we specialise in developing new synthesis methods and applying them to the construction of biologically important molecules. Over the years we have completed the total synthesis of many natural products, including: spongistatin 1 (anti-mitotic agent); rapamycin (immunosuppressant); thapsigargin (SERCA pumps inhibitor); azadirachtin (insect antifeedant); and bengazole A (fungicide). In addition to our research on natural product synthesis, we also pioneered flow chemistry and machine assisted synthesis.
For more detailed research information and our publication list, please see our legacy group website.
Completed Natural Products

Publications
Total synthesis of the plasmoidal pigment physarorubinic acid, a polyenoyl tetramic acid
J CHEM SOC PERK T 1
(1999)
2231
(doi: 10.1039/a904921e)
Total synthesis of the polyenoyltetramic acid mycotoxin erythroskyrine †
J CHEM SOC PERK T 1
(1999)
839
(doi: 10.1039/a809823i)
Highly cis- or trans-selective oxygen to carbon rearrangements of anomerically linked 6-substituted tetrahydropyranyl enol ethers
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1
(1999)
2665
(doi: 10.1039/a904891j)
Three-step synthesis of an array of substituted benzofurans using polymer-supported reagents
J CHEM SOC PERK T 1
(1999)
2421
(doi: 10.1039/a904384e)
Spect Tc 99m sestamibi in the evaluation of an an-tihypertensive drug (carvedilol) in heart failure (CHF) treatment.: Effect on coronary microcircula-tion
HYPERTENSION
(1999)
33
1307
Myocardiac ischemia induced by obstructive sleep apnea in the hypertensive morbidly without known heart disease demonstrated by (SPECT) Te 99m sestamibl preliminary report
HYPERTENSION
(1999)
33
1303
Prevalence of systemic hyprtension in morbid obesity.: Polysomnographic study.
HYPERTENSION
(1999)
33
1280
Spect Tc 99m sestamibi in the evaluation of an an-tihypertensive drug (carvedilol) in the heart failure (CHF) treatment, effect on coronary microcircula-tion
HYPERTENSION
(1999)
33
1088
Myocardial ischemia induced by obstructive sleep apnea in the hypertensive morbidly obese without known heart disease demonstrated by (SPECT) Tc 99m sestamibl preliminary report
HYPERTENSION
(1999)
33
1086
Prevalence of systemic hypertension in morbid obesity.: Polysomnographic study.
HYPERTENSION
(1999)
33
1076
- ‹ previous
- Page 68